Delivery Order SPE2DB22D1017-SPE2DB24FE7HZ

Award Date 10/19/23
Potential Completion Date 10/20/23
Potential Value $100
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $24,940 delivery order to Amerisourcebergen Drug Corporation for the supply of 0.05 mg estradiol patches to be delivered weekly in packages of four systems. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania over a one-day period from August 24-25, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for transdermal hormone therapy patches...
The Defense Logistics Agency awarded a $54,870 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 0.05 mg estradiol patches to be delivered over a one day period in September 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for transdermal hormone replacement patches aligns with the Defense Logistics...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety-six dollars and fifty-nine cents to Amerisourcebergen Drug Corporation for the supply of eight packages containing 0.075 mg estradiol patches to be applied twice weekly. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 21, 2023 through July 24, 2023. As a major provider of pharmaceuticals and medical supplies to the...
The Defense Logistics Agency awarded a $89,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 0.05 mg estradiol patches (1 per week) in quantities of 4. As the DLA supports procurement for the Department of Defense, this contract will provide hormone replacement therapy products to military treatment facilities and beneficiaries. Amerisourcebergen will fulfill the order from its Conshohocken, Pennsylvania distribution center. Performance is required...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $51,440 to Amerisourcebergen Drug Corporation for the supply of 0.1 mg estradiol patches (2 per week) in quantities of 8 systems. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a one-day period of performance from September 7-8, 2023. The Defense Logistics Agency facilitates procurement across all branches of...
Defense Logistics Agency awarded Amerisourcebergen Drug Corp a one hundred forty-nine dollar firm fixed price delivery order for estradiol 0.05 mg patches (1/wk) 4S. The order was issued against an unspecified contract vehicle and has an anticipated completion date of October 19, 2023. Place of performance will be in Conshohocken, Pennsylvania. No set aside designation was applied to this award to fulfill the Defense Logistics Agency's requirements for the referenced pharmaceutical product.
This delivery order was awarded on October 19, 2023 by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp for the provision of one hundred twelve dollars' worth of Estradiol 0.05 mg patches, one patch per week, in a quantity of four sets. The order is to be completed by October 20, 2023 under a firm fixed price contract. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No set-aside designation was applied to this award in...
The Defense Logistics Agency awarded a $74,820 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 0.05 mg estradiol patches to be delivered weekly in packages of four. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning July 27, 2023 through July 28, 2023 to fulfill the Defense Logistics Agency's requirements for this pharmaceutical product in support of...
The Defense Logistics Agency awarded a $89.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 0.0375mg estradiol patches (2 per week) in quantities of 8 systems. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the products from its Conshohocken, Pennsylvania facility on behalf of the Defense Logistics Agency, the logistics combat support agency of the Department of Defense. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $37,410 delivery order to Amerisourcebergen Drug Corporation for the supply of 0.075 mg estradiol patches to be delivered weekly in packages of four. The firm fixed price order is to be performed in Conshohocken, Pennsylvania between July 3 and July 5, 2023. No additional details were provided regarding the solicitation or any overarching contract vehicle. Amerisourcebergen will fulfill the order as prime contractor to supply the patches in support of the...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FE7HZ
    Delivery Order

Defense Logistics Agency awarded Amerisourcebergen Drug Corp a $99 firm fixed price delivery order for estradiol 0.05 mg patches (1/wk) 4S under contract number 4562531377. Place of performance will be Conshohocken, PA. The delivery order has a completion date of October 20, 2023 and was awarded on October 19, 2023 without a set-aside designation. As a major provider of pharmaceuticals, medical supplies, and equipment logistics services to the Department of Defense, this award will help DLA support military treatment facilities in providing hormone replacement therapies to beneficiaries.

Generated 1/18/24, 9:44 AM